Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Post-stroke depression: scientifically substantiated approaches to choosing therapy

https://doi.org/10.14412/2074-2711-2012-374

Full Text:

Abstract

The paper reviews the data available in the literature on the epidemiology of post-stroke depression (PSD), its pathogenetic mechanisms, and an association between stroke and depression. It gives the clinical types of PSD, the results of trials of the efficacy of antidepressants in these patients, and the use of escitalopram.

About the Author

Yulia Aleksandrovna Starchina

Department of Nervous Diseases, Faculty of Therapeutics


References

1. <div><p>Murray et al. WHO global health statistics, 1996.</p><p>Capaldi V.F., Wynn G.H. Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients. Psychol Res Behav Manag 2010;3:109-18.</p><p>Каннер А.М. Депрессия при неврологических заболеваниях. М.: Литтерра, 2007;159 с.</p><p>Ramasubbu R. Therapy for prevention of post-stroke depression. Exp opin Pharmacoter 2011;12(14):2177—87.</p><p>Вознесенская Т.Г. Депрессия при цереброваскулярных заболеваниях. Неврол нейропсихиатр психосом 2009;2:9-13.</p><p>Alexopoulos G.S., Meyers B.S., Young R.C. Vascular depression hypothesis. Arch Gen Psychiatry 1997;54:915-22.</p><p>Katon W.J. Clinical and health services relationship between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:21-6.</p><p>Lökk J., Delbar А. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat 2010;6:539-49.</p><p>Whyte E.M., Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002;52(3):253—64.</p><p>Berg A., Palomaki H. Poststroke depression. An 18-monthfollow-up. Stroke 2003,34:138—43.</p><p>Morris P.L.P., Robinson R.G., Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med 1990;20:349—64.</p><p>Hackett M., Anderson C. Treatment options for post-stroke depression in the elderly. Aging Health 2005;1(1):95—105.</p><p>Cummings J.L., Mega J.L. Disturbances of mood and affect: cerebrovascular disease. In: J.L. Cummings, J.L. Mega. Neuropsychiatry and behavioral neuroscience. New York, NY: Oxford University Press, 2003;206.</p><p>Starkstein S.E., Robinson R.G., Berther M.L. et al. Depressive disorders following posterior circulation as compared with middle cerebral artery infarcts. Brain 1988;11:375—87.</p><p>Chemerinski E., Robinson R.G. The neuropsychiatry of stroke. Psychosomatics 2000;41(1):5—14.</p><p>Lyness J.M. The cerebrovascular model of depression in late life. CNS Spectr 2002;7(10):712—5.</p><p>Turner-Stokes L., Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Clin Rehabil 2002;16(3):248—60.</p><p>Aben I., Verhey F., Lousberg R. et al. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 2002;43(5):386—93.</p><p>Chemerinski E., Robinson R.G., Kosier J.T. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001;32(1):113—7.</p><p>House A., Dennis M., Hawton K. et al. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire community stroke project. Age Ageing 1989;18(6):371—9.</p><p>Banasr M., Duman R.S. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 2007;6:311—20.</p><p>Li Y., Luikari B.W., Birnbaum S. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008;59:399—412.</p><p>Palomäki H., Kaste M., Berg A. et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999;66:490—4.</p><p>Jorge R.E., Robinson R.G., Arndt S. et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160:1823—9.</p><p>Robinson R.G., Jorge R.E., Moser D.J. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299(20):2391—400.</p><p>Hemeryck A., Belpaire F.M. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002;3(1):13—37.</p><p>Cipriani A., Furukawa T.A., Salanti G. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373(9665):746—58.</p><p>Choi-Kwon S., Han S.W., Kwon S.U. et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37(1):156—61.</p><p>Murray V., von Arbin M., Bartfai A. et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005;66(6):708—16.</p><p>Fruehwald S., Gatterbauer E., Rehak P. et al. Early fluoxetine treatment of poststroke depression-a three-month doubleblind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250(3):347—51.</p><p>Rasmussen A., Lunde M., Poulsen D.L. et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44(3):216—21.</p><p>Andersen G., Vestergaard K., Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099—104.</p><p>Jorge R.E., Acion L., Moser D. et al. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67(2):187—96.</p></div><br />


For citation:


Starchina Y.A. Post-stroke depression: scientifically substantiated approaches to choosing therapy. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1):116-120. (In Russ.) https://doi.org/10.14412/2074-2711-2012-374

Views: 421


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)